Terumo Overview

  • Year Founded
  • 1921

Year Founded

  • Status
  • Public

  • Employees
  • 30,207


  • Stock Symbol
  • 4543

Stock Symbol

  • Investments
  • 24

  • Share Price
  • $17.53
  • (As of Friday Closing)

Terumo General Information


Terumo Corp manufactures and sells medical products and equipment. The firm has three main businesses: blood management, cardiac and vascular, and general hospital. The cardiac and vascular business generates the largest proportion of revenue and sells cardiac and endovascular interventional therapies, cardiovascular surgical systems, neurovascular products, and vascular graft products. The general hospital business includes diabetes management, consumer healthcare, drug and device technologies, and general hospital products. The blood management business sells blood component, therapeutic apheresis, and cellular technologies. Terumo generates the majority of its revenue in Asia, with Japan contributing the largest proportion of Asian revenue.

Contact Information

Formerly Known As
Red Line Thermometer Corporation
Ownership Status
Publicly Held
Financing Status
Primary Industry
Medical Supplies
Other Industries
Other Devices and Supplies
Stock Exchange
Corporate Office
  • 2-44-1 Hatagaya
  • Shibuya-ku
  • Tokyo, 151-0072
  • Japan
+81 00-0000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Terumo Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$17.53 $18.11 $12.40 - $20.08 $26B 1.48B 3.61M $0.49

Terumo Financials Summary

In Thousands,
TTM 31-Mar-2024 FY 2024 31-Mar-2024 FY 2023 31-Mar-2023 FY 2022 31-Mar-2022
EV 26,885,781 26,885,781 20,220,062 23,468,696
Revenue 6,380,123 6,380,123 6,058,487 6,260,305
EBITDA 1,500,590 1,500,590 1,386,759 1,560,236
Net Income 736,204 736,204 659,801 790,550
Total Assets 12,100,443 12,100,443 12,024,538 12,074,704
Total Debt 1,531,867 1,531,867 1,740,664 1,851,698
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Terumo Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Terumo‘s full profile, request access.

Request a free trial

Terumo Comparisons

HQ Location
Total Raised
Post Valuation
Terumo Corp manufactures and sells medical products and equipment. The firm has three main businesses: blood management,
Medical Supplies
Tokyo, Japan
30,207 As of 2023


t ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exerci
0000000000 000000000
Tokyo, Japan
0000 As of 0000


sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labor
00000000 0000000
New York, NY
000 As of 0000
000000000 00 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Terumo Competitors (46)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nihon Kohden Corporation Tokyo, Japan 0000 00000000
Angiodynamics Private Debt Financed New York, NY 000 00000 000000000 00 00000
Edwards Lifesciences Corporation Irvine, CA 00000 00.000 000000000 00.000
Penumbra Formerly VC-backed Alameda, CA 0000 0000 00000000 0000
Becton, Dickinson and Company Corporation Franklin Lakes, NJ 00000 000.00 000000000 00 000.00
You’re viewing 5 of 46 competitors. Get the full list »

Terumo Patents

Terumo Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2024057162-A Retaining fixture Pending 12-Oct-2022
JP-2024057161-A Container Pending 12-Oct-2022
JP-2024054796-A Electronic thermometer, temperature measurement method, and program Pending 05-Oct-2022
JP-2024052416-A Catheter and method for manufacturing the same Pending 30-Sep-2022
JP-2024051777-A Selection assistance program, selection assistance device, selection assistance method, and model generation method Pending 30-Sep-2022
To view Terumo’s complete patent history, request access »

Terumo Executive Team (23)

Name Title Board Seat Contact Info
Shinjiro Sato Chief Executive Officer & Board Member
Hikaru Samejima President, Medical Care Solutions Company
Naoki Muto Chief Accounting and Financial Officer, Executive Officer in charge of Controller Department, Treasury Department, Tax Department.
Shinji Omori Ph.D Chief Technology Officer
Miho Mizuguchi Chief Legal Officer & General Manager, Legal and Compliance Department
You’re viewing 5 of 23 executive team members. Get the full list »

Terumo Board Members (8)

Name Representing Role Since
Kazunori Hirose Terumo Board Member & Executive 000 0000
Keiya Ozawa Terumo Board Member 000 0000
Shinjiro Sato Terumo Chief Executive Officer & Board Member 000 0000
Shoji Hatano Terumo Board Member & Executive 000 0000
Toshiaki Takagi Terumo Board Member & Executive 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Terumo Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Terumo Investments & Acquisitions (24)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Orchestra BioMed 05-Jul-2022 00000 0000 00000 Therapeutic Devices
Diabeloop 02-Jun-2022 00000 0000 0000 Monitoring Equipment 000000 00
Health Outcomes Sciences 24-Feb-2021 0000000000 Decision/Risk Analysis 00000 000
ReThink Medical 11-Aug-2020 0000000000 Monitoring Equipment
Quirem Medical 15-Jul-2020 Merger/Acquisition 0000 Monitoring Equipment 00000 000
You’re viewing 5 of 24 investments and acquisitions. Get the full list »

Terumo Subsidiaries (5)

Company Name Industry Location Founded
Quirem Medical Monitoring Equipment Deventer, Netherlands 2013
Terumo China China 0000
MicroVention Terumo Drug Discovery Aliso Viejo, CA 0000
Terumo Medical Other Devices and Supplies Somerset, NJ 0000
TerumoBCT Biotechnology Lakewood, CO 0000
To view Terumo’s complete subsidiaries history, request access »

Terumo ESG

Risk Overview

Risk Rating

Updated April, 27, 2024

23.6 | Med Risk

Risk Scale

A lower score indicates better sustainability












Exposure refers to the extent to which a company is exposed to different material ESG issues



Management is related to actions taken to manage ESG issues


Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.


Covered Companies

00 of 16,421






00 of 645




Medical Devices


00 of 228




To view Terumo’s complete esg history, request access »

Terumo Exits (6)

Company Name Exit Date Exit Type Exit Size Status Buyers
Orchestra BioMed 05-Jul-2022 00000 00000 00 00000 Completed
  • 7 buyers
Cuorips 12-Apr-2020 00000 00000 00 000.00 Completed
  • 3 buyers
Orchestra BioMed 07-May-2019 00000 00000 00 0000 Completed
  • 7 buyers
Cuorips 11-Jul-2018 0000 00000 Completed
  • 3 buyers
Olympus Terumo Biomaterials 14-Dec-2006 Secondary Transaction - Private Completed
You’re viewing 5 of 6 exits. Get the full list »

Terumo FAQs

  • When was Terumo founded?

    Terumo was founded in 1921.

  • Who is the CEO of Terumo?

    Shinjiro Sato is the CEO of Terumo.

  • Where is Terumo headquartered?

    Terumo is headquartered in Tokyo, Japan.

  • What is the size of Terumo?

    Terumo has 30,207 total employees.

  • What industry is Terumo in?

    Terumo’s primary industry is Medical Supplies.

  • Is Terumo a private or public company?

    Terumo is a Public company.

  • What is Terumo’s stock symbol?

    The ticker symbol for Terumo is 4543.

  • What is the current stock price of Terumo?

    As of 17-May-2024 the stock price of Terumo is $17.53.

  • What is the current market cap of Terumo?

    The current market capitalization of Terumo is $26B.

  • What is Terumo’s current revenue?

    The trailing twelve month revenue for Terumo is $6.38B.

  • Who are Terumo’s competitors?

    Nihon Kohden, Angiodynamics, Edwards Lifesciences, Penumbra, and Becton, Dickinson and Company are some of the 46 competitors of Terumo.

  • What is Terumo’s annual earnings per share (EPS)?

    Terumo’s EPS for 12 months was $0.49.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »